Ojjaara (momelotinib), for the treatment of intermediate or side effect associated with other JAK inhibitors, Ojjaara could have
What are the possible side effects of OJJAARA? OJJAARA may cause serious side effects, including: Risk of Infections. People who take OJJAARA may develop
Learn about Ojjaara including its uses, possible side effects, drug interactions, images, warnings and similar drugs. Ojjaara prices starting at $ .08.
OJJAARA may cause serious side effects, including: Risk of Infections. People who take OJJAARA may develop serious infections that can lead to death, such as
OJJAARA may cause serious side effects, including: Risk of Infections. People who take OJJAARA may develop serious infections that can lead to death, such as bacterial and viral infections, including COVID-19. If you have an active infection, your healthcare provider should not start treatment with OJJAARA until your infection is gone.
Andrew is hopeful that this is the first of many for people struggling with this disease. Ojjaara The main side effects are low platelet
Ojjaara (momelotinib) approved in the US as the first and only treatment indicated for myelofibrosis patients with anaemia Ojjaara is a once-a
More about Ojjaara (momelotinib) Check interactions; Compare alternatives; Pricing coupons; Reviews (3) Drug images; Side effects; During pregnancy; FDA approval history; Drug class: multikinase inhibitors; Breastfeeding; En espa ol; Patient resources. Ojjaara drug information; Professional resources. Ojjaara prescribing information
Ojjaara is a prescription medication used to treat myelofibrosis (MF) in adults with anemia. Ojjaara may cause serious infections, heart attack, stroke, and death. The most common side effects of Ojjaara include low platelet count, dizziness, bleeding, diarrhea, bacterial infection, nausea, and tiredness.
Comments
one of my own pet peeves, sorry